Efficacy of a combination of imatinib and low dose ara-C in elderly or high-risk patients with AML and MDS, as measured by the rate of early mortality or progression. April 2007 [clinicaltrials_resource:7be1cfed15212dd7e3b4d5da1a8b3ed4]
600 mg (capsules) by mouth once daily
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Efficacy of a combination of imatinib and low dose ara-C in elderly or high-risk patients with AML and MDS, as measured by the rate of early mortality or progression. April 2007 [clinicaltrials_resource:7be1cfed15212dd7e3b4d5da1a8b3ed4]
600 mg (capsules) by mouth once daily
Bio2RDF identifier
7be1cfed15212dd7e3b4d5da1a8b3ed4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7be1cfed15212dd7e3b4d5da1a8b3ed4
measure [clinicaltrials_vocabulary:measure]
Efficacy of a combination of i ...... arly mortality or progression.
time frame [clinicaltrials_vocabulary:time-frame]
April 2007
description
600 mg (capsules) by mouth once daily
identifier
clinicaltrials_resource:7be1cfed15212dd7e3b4d5da1a8b3ed4
title
Efficacy of a combination of i ...... ity or progression. April 2007
@en
type
label
Efficacy of a combination of i ...... 1cfed15212dd7e3b4d5da1a8b3ed4]
@en